Endocrine, Metabolic, Cardiovascular and Immunological Aspects of Sex Chromosome Abnormalities in Relation to Genotype
Launched by UNIVERSITY OF AARHUS · Jun 15, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain changes in our genes, specifically those related to sex chromosomes, affect various health aspects like metabolism, heart health, and the immune system. The researchers are looking at two groups: one group of 160 patients with sex chromosome abnormalities, like Klinefelter Syndrome and Turner Syndrome, and a matched group of 160 people without these conditions. They will collect samples like blood and urine, and also perform tests on bones and liver to understand how these genetic differences influence health.
To be eligible for this study, participants need to have a documented sex chromosome abnormality. Once enrolled, participants can expect to answer questionnaires and undergo several tests, including scans of their bones and liver, as well as blood tests to check for various health markers. This research aims to uncover important connections between genetics and health, which could lead to improved understanding and treatment options for those with sex chromosome abnormalities. If you or a loved one are interested in participating, know that all genders are welcome, and the study is currently recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must have the sex-chromosome abnormality
- Exclusion Criteria:
- • -
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Aarhus, , Denmark
Patients applied
Trial Officials
Claus Gravholt, Prof
Study Director
Aarhus University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials